Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

Saved in:
Bibliographic Details
Title: Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Authors: Davies F; NYU Langone Health, New York, NY, USA. faith.davies@nyulangone.org., Rifkin R; Rocky Mountain Cancer Centers, Denver, CO, USA., Costello C; Moores Cancer Center, University of California, San Diego, CA, USA., Morgan G; NYU Langone Health, New York, NY, USA., Usmani S; Carolinas Healthcare System, Charlotte, NC, USA., Abonour R; Indiana University, Indianapolis, IN, USA., Palumbo A; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Romanus D; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Hajek R; University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Terpos E; University of Athens School of Medicine, Athens, Greece., Cherepanov D; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Stull DM; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Huang H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Leleu X; CHU la Miletrie, Poiters, France., Berdeja J; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA., Lee HC; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Thompson M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, WI, USA., Boccadoro M; Azienda Ospedaliera Citta della Salute e della Scienza, Torino, Italy., Zonder J; Karmanos Cancer Institute, Detroit, MI, USA., Cook G; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Puig N; Salamanca University Hospital, Salamanca, Spain., Vela-Ojeda J; Hospital de Especialidades Centro Medico Nacional la Raza, Mexico City, Mexico., Farrelly E; Xcenda, Palm Harbor, FL, USA., Raju A; Xcenda, Palm Harbor, FL, USA., Blazer M; Xcenda, Palm Harbor, FL, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Source: Annals of hematology [Ann Hematol] 2021 Sep; Vol. 100 (9), pp. 2325-2337. Date of Electronic Publication: 2021 May 10.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0584
DOI:10.1007/s00277-021-04534-8